Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Conditions:   Vestibular Diseases;   Vestibular Neuronitis
    Interventions:   Drug: Betamethasone;   Drug: Placebo;   Drug: Prednisolone
    Sponsor:   Lund University
    Recruiting - verified September 2016

  • Conditions:   Cluster Headache;   Cluster Headaches and Other Trigeminal Autonomic Cephalgias;   Paroxysmal Hemicrania;   SUNCT;   Hemicrania Continua;   Trigeminal Neuralgia
    Intervention:  
    Sponsor:   The University of Texas Health Science Center, Houston
    Recruiting - verified September 2016

  • Condition:   Optic Neuritis
    Intervention:   Device: pupillary light reflex
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting - verified August 2016

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica Spectrum Disorders
    Intervention:  
    Sponsor:   Hospices Civils de Lyon
    Recruiting - verified August 2016

  • Condition:   Optic Neuritis
    Intervention:   Biological: blood test of anti-AQP4 antibody
    Sponsor:   Xiujuan Zhao
    Recruiting - verified August 2016

  • Condition:   Optic Neuritis
    Intervention:  
    Sponsor:   Laval University
    Recruiting - verified August 2016

  • Condition:   Cerebrospinal Fluid Leak
    Interventions:   Drug: FS VH S/D 500 s-apr;   Device: DuraSeal Dural Sealant
    Sponsor:   Baxter Healthcare Corporation
    Not yet recruiting - verified September 2016

  • Conditions:   Neuromyelitis Optica Spectrum Disorders;   Neuromyelitis Optica Spectrum Related Disorders
    Intervention:  
    Sponsor:   Hospices Civils de Lyon
    Recruiting - verified July 2016

  • Condition:   Stage IV EGFR Mutated NSCL With Brain Metastases
    Interventions:   Drug: Gefitinib 250mg po qd or Tarceva 150mg po qd or Icotinib 125mg po tid Other Name: Gefitinib/Tarceva/Icotinib;   Radiation: WBRT;   Radiation: HFSRS
    Sponsor:   Sichuan Provincial People's Hospital
    Recruiting - verified August 2016

  • Conditions:   Appearance Distress;   Bothered by Itching Skin;   Cafe Au Lait Spot;   Cutaneous Neurofibroma;   Disfigurement;   Dysplasia;   Lisch Nodule;   Neurofibromatosis Type 1;   NF1 Gene Mutation;   Optic Nerve Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Drug: Selumetinib
    Sponsor:   National Cancer Institute (NCI)
    Not yet recruiting - verified July 2016

  • Condition:   Unilateral Peripheral Facial Paralysis
    Interventions:   Other: Neuromuscular Retraining and Virtual therapy;   Other: Oro-myo-functional classical rehabilitation
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified July 2016

  • Conditions:   Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
    Interventions:   Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin
    Sponsor:   Hadassah Medical Organization
    Not yet recruiting - verified August 2016

  • Conditions:   Orofacial Pain;   Trigeminal Neuralgia
    Intervention:   Other: occlusal adjustment
    Sponsor:   Meiqing Wang
    Recruiting - verified August 2016

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica Spectrum Disorders
    Intervention:   Other: Magnetic Resonance Imaging
    Sponsor:   Chinese PLA General Hospital
    Recruiting - verified August 2016

  • Condition:   Injury of Facial Nerve, Unspecified Side, Initial Encounter
    Interventions:   Biological: Autologous adipose stem cell therapy;   Drug: Mecobalamin
    Sponsor:   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
    Not yet recruiting - verified August 2016

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: BIIB074;   Drug: Placebo
    Sponsor:   Biogen
    Recruiting - verified September 2016

  • Conditions:   Neurofibromatosis 2;   Meningioma
    Intervention:   Drug: AZD2014
    Sponsors:   Massachusetts General Hospital;   AstraZeneca;   United States Department of Defense
    Not yet recruiting - verified July 2016

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsor:   Washington University School of Medicine
    Not yet recruiting - verified July 2016

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting - verified July 2016

  • Condition:   Meningiomas of the Middle Cranial Fossa
    Intervention:   Other: surgery
    Sponsor:   Kasr El Aini Hospital
    Recruiting - verified August 2016

  • Condition:   Progressive Supranuclear Palsy (PSP)
    Interventions:   Drug: Rivastigmine;   Drug: Placebo
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Recruiting - verified August 2016

  • Conditions:   Glaucoma;   Retinal Disease;   Strabismus;   Healthy Volunteers
    Intervention:   Device: Binocular OCT prototype
    Sponsor:   University College, London
    Recruiting - verified June 2016

  • Condition:   Neurofibromatosis 2
    Interventions:   Behavioral: Stress Management Group 1;   Behavioral: Stress Management Group 2
    Sponsors:   Massachusetts General Hospital;   The Children's Tumor Foundation
    Not yet recruiting - verified June 2016

  • Condition:   Intermittent Exotropia
    Interventions:   Device: Overminus treatment;   Device: Non-overminus treatment
    Sponsors:   Jaeb Center for Health Research;   Pediatric Eye Disease Investigator Group;   National Eye Institute (NEI)
    Not yet recruiting - verified August 2016

  • Condition:   Trigeminal Neuralgia
    Intervention:   Device: PainShield SAW Patch Device
    Sponsors:   Rosenblum, Jonathan I., DPM;   Nanovibronix
    Not yet recruiting - verified June 2016

  • Condition:   Leber's Hereditary Optic Neuropathy (LHON)
    Intervention:  
    Sponsor:   Santhera Pharmaceuticals
    Recruiting - verified June 2016

  • Conditions:   Childhood Brain Stem Neoplasm;   Childhood Lymphoma;   Childhood Solid Neoplasm;   Pineal Region Neoplasm;   Recurrent Childhood Central Nervous System Neoplasm;   Recurrent Childhood Visual Pathway Glioma;   Refractory Central Nervous System Neoplasm
    Interventions:   Drug: Entinostat;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
    Sponsor:   National Cancer Institute (NCI)
    Not yet recruiting - verified August 2016

  • Conditions:   Pain;   Nausea
    Interventions:   Drug: Hydromorphone;   Drug: Fentanyl
    Sponsor:   St. Louis Children's Hospital
    Recruiting - verified June 2016

  • Conditions:   Stroke;   Head Trauma
    Intervention:   Other: Patient Specific Implant
    Sponsor:   University Hospital Inselspital, Berne
    Not yet recruiting - verified July 2016

  • Condition:   Pupillary Findings Related to Third Cranial Nerve Disorders
    Intervention:  
    Sponsors:   University of Texas Southwestern Medical Center;   NeurOptics Inc.
    Recruiting - verified June 2016

  • Condition:   Leber's Hereditary Optic Neuropathy (LHON)
    Intervention:   Drug: Idebenone
    Sponsor:   Santhera Pharmaceuticals
    Recruiting - verified May 2016

  • Condition:   Intermittent Exotropia
    Intervention:   Device: Controlled Intermittent Alternate Occlusion (CIAO ) glasses
    Sponsor:   Salus University
    Not yet recruiting - verified September 2016

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: I-Bit plus
    Sponsors:   Nottingham University Hospitals NHS Trust;   National Institute for Health Research, United Kingdom;   Wellcome Trust
    Not yet recruiting - verified June 2016

  • Condition:   Leber's Hereditary Optic Neuropathy (LHON)
    Intervention:   Drug: Idebenone
    Sponsor:   Santhera Pharmaceuticals
    Not yet recruiting - verified May 2016

  • Condition:   Corneal Dystrophy, Epithelial Basement Membrane
    Intervention:   Device: cryopreserved amniotic membrane
    Sponsor:   Tissue Tech Inc.
    Recruiting - verified May 2016

  • Conditions:   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration;   Multiple System Atrophy (MSA)
    Intervention:  
    Sponsors:   University College, London;   University of Cambridge;   University of Oxford;   University of Manchester;   Newcastle University;   University of Sussex;   Royal Gwent Hospital
    Recruiting - verified April 2016

  • Conditions:   Parkinson's Disease;   Alzheimer's Disease;   Progressive Supranuclear Palsy;   Essential Tremor;   Multiple System Atrophy;   Drug Induced Parkinson's Disease;   Diffuse Lewy Body Disease;   Myasthenia Gravis
    Interventions:   Other: Electrical Brainstem Responses;   Other: Olfactory Tests;   Other: Visual Deprivation
    Sponsors:   University of Pennsylvania;   Michael J. Fox Foundation for Parkinson's Research
    Not yet recruiting - verified May 2016

  • Condition:   Moderate Intermittent Exotropia
    Intervention:   Procedure: recession or resection of the horizontal extraocular muscles
    Sponsor:   Sun Yat-sen University
    Recruiting - verified April 2016

  • Conditions:   Orbital Fractures;   Strabismus
    Intervention:   Procedure: Floor repair surgery
    Sponsor:   Tri-Service General Hospital
    Not yet recruiting - verified April 2016

  • Condition:   Cerebrospinal Fluid Leak
    Intervention:   Drug: Acetazolamide 500 mg bid
    Sponsor:   University of Miami
    Not yet recruiting - verified September 2016

  • Condition:   Traumatic Optic Neuropathy
    Interventions:   Procedure: Optic canal and optic nerve sheath decompression;   Drug: methylprednisolone
    Sponsors:   Shanghai Changzheng Hospital;   RenJi Hospital
    Recruiting - verified March 2016

  • Condition:   Trigeminal Neuralgia
    Intervention:  
    Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
    Not yet recruiting - verified March 2016

  • Condition:   Exotropia or Intermittent Exotropia
    Interventions:   Device: lateral rectus recession with biodegradable collagen implant;   Procedure: Lateral rectus recession without biodegradable collagen implantation
    Sponsor:   Yonsei University
    Recruiting - verified February 2016

  • Conditions:   Anxiety;   Strabismus;   Compliance
    Intervention:  
    Sponsors:   Queen's University;   University of Regina
    Recruiting - verified March 2016

  • Condition:   Leber's Hereditary Optic Neuropathy
    Interventions:   Drug: elamipretide (MTP-131) 1% topical ophthalmic solution;   Drug: Vehicle topical ophthalmic solution
    Sponsor:   Stealth BioTherapeutics Inc.
    Recruiting - verified June 2016

  • Condition:   Mandibular Neoplasms
    Intervention:   Procedure: inferior alveolar nerve block
    Sponsor:   Tata Memorial Centre
    Not yet recruiting - verified April 2016

  • Condition:   Intracranial Aneurysm
    Intervention:   Device: Pipeline™ Flex Embolization Device with Shield Technology™
    Sponsors:   Medtronic Neurovascular Clinical Affairs;   Medtronic Bakken Research Center
    Recruiting - verified March 2016

  • Conditions:   Head and Neck Neoplasms;   Accessory Nerve Injury;   Fatigue
    Interventions:   Behavioral: Therapeutic Exercise;   Behavioral: Therapeutic + Lower Body Exercise
    Sponsors:   University of Alberta;   Cross Cancer Institute
    Recruiting - verified January 2016

  • Condition:   Trochlear Nerve Diseases
    Intervention:   Device: Heidelberg Spectralis OCT device
    Sponsor:   University of Zurich
    Recruiting - verified December 2015

  • Conditions:   Trigeminal Nerve Injuries;   Post-herpetic Neuralgia;   Facial Pain;   Nervus Intermedius Neuralgia
    Intervention:   Device: transcranial magnetic stimulation
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting - verified August 2016

  • Conditions:   Trigeminal Neuralgia;   Headache Disorders
    Intervention:   Drug: Glycerol
    Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital
    Recruiting - verified June 2016

  • Conditions:   Trigeminal Neuralgia;   Headache Disorders
    Intervention:   Drug: Botulinum Toxin Type A
    Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital
    Recruiting - verified June 2016

  • Condition:   Trigeminal Neuralgia
    Interventions:   Device: Unframed Virtual Cone;   Radiation: 80 Gy of Radiation
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified September 2016

  • Conditions:   Dizziness;   Vertigo;   Vestibular Neuritis
    Interventions:   Behavioral: BI + VR + CBT;   Behavioral: BI + phone calls
    Sponsors:   Bergen University College;   University of Bergen;   Norwegian Fund for Postgraduate Training in Physiotherapy;   University of Southern Denmark;   Duke University;   Haukeland University Hospital
    Recruiting - verified September 2016

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting - verified May 2016

  • Conditions:   Neurofibromatosis Type 2;   Severe Profound Sensorineural Hearing Loss
    Intervention:   Device: Nucleus Profile ABI541 Auditory Brainstem Implant
    Sponsor:   Massachusetts Eye and Ear Infirmary
    Available - verified July 2016

  • Conditions:   Laryngeal Carcinoma;   Bilateral Vocal Cord Paresis;   Subglottic Stenosis
    Interventions:   Procedure: laryngeal carcinoma;   Procedure: bilateral vocal cord paralysis;   Procedure: subglottic stenosis
    Sponsor:   University Hospital Ostrava
    Recruiting - verified September 2016

  • Conditions:   Migraine Headache;   Headache
    Intervention:  
    Sponsor:   Children's Hospitals and Clinics of Minnesota
    Recruiting - verified April 2016

  • Condition:   Optic Nerve Sheath Tumors, Benign
    Intervention:   Radiation: Multisession Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting - verified November 2015

  • Conditions:   Ischemic Stroke;   Hemorrhagic Stroke
    Intervention:  
    Sponsor:   Third Military Medical University
    Recruiting - verified June 2016

  • Conditions:   Mandibular Fracture Trauma;   Orthognathic Surgery;   Maxillofacial Osteotomy
    Intervention:   Procedure: Realization of the V3 block in maxillofacial surgeries
    Sponsor:   University Hospital, Montpellier
    Not yet recruiting - verified November 2015

  • Condition:   Esthesioneuroblastoma, Olfactory
    Intervention:  
    Sponsor:   Ricardo L. Carrau, MD
    Recruiting - verified October 2015

  • Conditions:   Retinal Diseases;   Optic Nerve Diseases
    Intervention:   Device: Duke Biomedical Engineering's Long-working distance OCT
    Sponsors:   Duke University;   Johns Hopkins University;   The Hartwell Foundation
    Recruiting - verified August 2016

  • Condition:   Dystonia
    Interventions:   Procedure: Stimulation;   Procedure: Sham-stimulation
    Sponsors:   Beijing Tiantan Hospital;   Peking Union Medical College Hospital;   The First Affiliated Hospital of Dalian Medical University;   China-Japan Friendship Hospital
    Recruiting - verified October 2015

  • Conditions:   Amblyopia;   Strabismus
    Interventions:   Device: Pediatric Vision Scanning device;   Other: Reference examination
    Sponsors:   Rebiscan, Inc.;   Kaiser Foundation Research Institute
    Recruiting - verified September 2016

  • Condition:   Optic Neuritis
    Interventions:   Drug: Clemastine;   Drug: Placebo
    Sponsor:   University of California, San Francisco
    Not yet recruiting - verified May 2016

  • Conditions:   Glaucoma;   Intraocular Pressure;   Optic Neuropathy
    Intervention:   Device: Intra-ocular Pressure meas
    Sponsor:   Wills Eye
    Recruiting - verified November 2015

  • Conditions:   Convergence Insufficiency;   Divergence Insufficiency;   Hypertropia
    Interventions:   Device: Prism;   Other: Orthoptic Exercises;   Procedure: Eye Muscle Surgery;   Procedure: Botox Injection
    Sponsors:   Jaeb Center for Health Research;   Pediatric Eye Disease Investigator Group;   National Eye Institute (NEI)
    Recruiting - verified June 2016

  • Condition:   Facial Nerve Palsy
    Interventions:   Device: MyotonPRO;   Device: non-invasive electromyography (EMG)
    Sponsor:   Universitair Ziekenhuis Brussel
    Recruiting - verified August 2016

  • Conditions:   Alzheimer's Disease (AD);   Progressive Supranuclear Palsy (PSP);   Cortical Basal Syndrome (CBS);   Frontal Temporal Dementia (FTD)
    Intervention:   Drug: [18F]MNI-815 (MNI-815)
    Sponsors:   Molecular NeuroImaging;   Piramal Imaging SA
    Recruiting - verified April 2016

  • Conditions:   Maternal-Fetal Relations;   Microcephaly
    Intervention:   Other: no intervention
    Sponsor:   Clalit Health Services
    Recruiting - verified January 2016

  • Condition:   Trigeminal Neuralgia
    Intervention:   Drug: Carbon Dioxide Drug Delivery System (CDDS)
    Sponsor:   Capnia, Inc.
    Recruiting - verified September 2016

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Other: Fresh Frozen Plasma
    Sponsor:   University of California, San Francisco
    Recruiting - verified May 2016

  • Condition:   Strabismus
    Interventions:   Drug: High dose remifentanil;   Drug: Low dose remifentanil;   Drug: No remifentanil
    Sponsor:   Inje University
    Recruiting - verified August 2016

  • Conditions:   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy;   Vascular Parkinsonism
    Intervention:   Other: MRI exam of the brain
    Sponsors:   University Hospital, Montpellier;   Novartis
    Recruiting - verified October 2015

  • Condition:   Trigeminal Neuralgia
    Interventions:   Procedure: Balloon Compression Rhizotomy;   Procedure: Radiofrequency Thermal Coagulation Rhizotomy
    Sponsor:   University of Sao Paulo
    Recruiting - verified January 2016

  • Condition:   Intermittent Exotropia
    Intervention:   Device: CIAO therapy Amblyz glasses
    Sponsor:   Indiana University School of Medicine
    Recruiting - verified March 2016

  • Conditions:   Neurofibromatosis Type 1;   Recurrent Central Nervous System Neoplasm;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Visual Pathway Glioma;   Refractory Central Nervous System Neoplasm
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Pomalidomide
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified July 2016

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Drug: Salsalate
    Sponsor:   Adam Boxer
    Recruiting - verified January 2016

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness Clinical Research Institute
    Recruiting - verified March 2016

  • Condition:   Diffuse Brain Injury
    Interventions:   Other: placebo;   Device: "Luminette",Lucimed Belgium
    Sponsors:   Centre d'Investigation Clinique et Technologique 805;   Fondation Garches
    Recruiting - verified July 2016

  • Conditions:   Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
    Intervention:  
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified January 2016

  • Conditions:   Multiple Sclerosis;   Internuclear Ophthalmoplegia;   Fatigue
    Interventions:   Drug: Dalfampridine;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting - verified September 2016

  • Condition:   Optic Nerve Disorders
    Intervention:  
    Sponsor:   University of Colorado, Denver
    Recruiting - verified April 2016

  • Condition:   Optic Nerve Diseases
    Interventions:   Drug: Erythropoietin;   Other: placebo
    Sponsor:   Tehran University of Medical Sciences
    Recruiting - verified April 2016

  • Conditions:   Corneal Dystrophy, Epithelial Basement Membrane;   Epithelial Recurrent Erosion Dystrophy;   Corneal Erosions
    Interventions:   Device: Cacicol20;   Device: Placebo
    Sponsors:   Neil Lagali;   Region Östergötland;   Linkoeping University;   Sahlgrenska University Hospital, Sweden;   Laboratoires Thea
    Recruiting - verified October 2015

  • Conditions:   Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
    Interventions:   Procedure: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
    Sponsor:   Washington University School of Medicine
    Recruiting - verified August 2016

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting - verified April 2016

  • Condition:   Myofacial Pain Syndromes
    Interventions:   Device: Intravascular laser irradiation of blood (ILIB);   Device: Transcutaneous electrical nerve stimulation;   Other: Stretching exercise
    Sponsor:   Chang Gung Memorial Hospital
    Recruiting - verified July 2016

  • Condition:   Strabismus
    Intervention:   Other: Examination of the eye
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Recruiting - verified September 2016

  • Condition:   Vestibular Schwannoma
    Intervention:   Drug: Gentamicin
    Sponsor:   Lund University
    Recruiting - verified September 2016

  • Condition:   Vestibular Schwannoma
    Intervention:   Drug: Gentamicins
    Sponsor:   Lund University
    Recruiting - verified September 2016

  • Condition:   Nonarteritic Anterior Ischemic Optic Neuropathy
    Interventions:   Drug: QPI-1007 Injection - single low dose;   Drug: QPI-1007 Injection - single high dose;   Drug: QPI-1007 Injection - multiple low dose;   Drug: QPI-1007 Injection - multiple high dose;   Other: Sham Injection Procedure
    Sponsor:   Quark Pharmaceuticals
    Recruiting - verified September 2016

  • Conditions:   Juvenile Pilocytic Astrocytomas;   Optic Pathway Gliomas
    Intervention:   Drug: Pegylated interferon alpha-2b
    Sponsors:   Emory University;   CURE Childhood Cancer, Inc.
    Recruiting - verified April 2016

  • Conditions:   Trigeminal Neuralgia (Burchiel Type I);   Trigeminal Neuralgia (Burchiel Type II);   Trigeminal Neuropathic Pain;   Trigeminal Deafferentation Pain;   Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity);   Glossopharyngeal Neuralgia;   Upper Extremity Pain Due to Deafferentation of the Cervical Spine;   Central Pain Syndromes
    Intervention:   Device: Epidural Motor Cortex Stimulation
    Sponsor:   Johns Hopkins University
    Recruiting - verified August 2016

  • Condition:   Traumatic Brain Injury
    Interventions:   Device: neuroConn_CE_DC-STIMULATOR;   Device: neuroConn_CE_DC-STIMULATOR;   Device: SHAM
    Sponsor:   Loewenstein Hospital
    Recruiting - verified March 2016

  • Conditions:   Unilateral Acoustic Neuroma;   Meniere's Disease
    Intervention:   Device: Cochlear Implant
    Sponsors:   University of North Carolina, Chapel Hill;   Med-El Corporation
    Recruiting - verified September 2016

  • Conditions:   Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
    Intervention:   Drug: AR-42
    Sponsors:   Massachusetts Eye and Ear Infirmary;   Johns Hopkins University;   Mayo Clinic;   Stanford University;   Ohio State University;   Nationwide Children's Hospital
    Recruiting - verified May 2016

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica
    Intervention:   Biological: Tolerogenic Dendritic cells loaded with myelin peptides
    Sponsor:   Sara Varea
    Recruiting - verified May 2016

  • Condition:   Mandibular Fractures
    Intervention:   Procedure: Implants
    Sponsors:   AO Clinical Investigation and Documentation;   AOCMF
    Recruiting - verified July 2016

  • Condition:   Vestibular Schwannoma
    Intervention:   Other: Preoperative vestibular rehabilitation
    Sponsors:   Central Hospital, Nancy, France;   University of Lorraine
    Recruiting - verified June 2016

  • Condition:   Ataxia-oculomotor Apraxia 1
    Interventions:   Dietary Supplement: CoQ10;   Other: Sanomit Placebo
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting - verified May 2016

  • Condition:   Vestibular Schwannoma
    Intervention:   Radiation: gamma knife radiosurgery
    Sponsor:   Haukeland University Hospital
    Recruiting - verified February 2016

  • Conditions:   Tbi;   Intracranial Edema;   Brain Edema;   Craniocerebral Trauma;   Head Injury;   Brain Hemorrhage, Traumatic;   Subdural Hematoma;   Brain Concussion;   Head Injuries, Closed;   Epidural Hematoma;   Cortical Contusion;   Wounds and Injuries;   Disorders of Environmental Origin;   Trauma, Nervous System;   Brain Injuries
    Interventions:   Behavioral: Therapist Guided Face to Face Family Problem Solving;   Behavioral: Therapist Guided Online Family Problem Solving;   Behavioral: Self-Guided Online Family Problem Solving
    Sponsors:   Children's Hospital Medical Center, Cincinnati;   Case Western Reserve University;   Children's Hospital Colorado;   MetroHealth Medical Center;   Nationwide Children's Hospital;   Patient-Centered Outcomes Research Institute
    Recruiting - verified July 2016

  • Conditions:   Amblyopia;   Anisometropia;   Strabismus
    Interventions:   Device: Dichoptic therapy;   Other: Patching therapy;   Device: Dioptic (non-dichoptic) therapy
    Sponsor:   University of California, San Francisco
    Recruiting - verified December 2015

  • Condition:   Fracture Mandible
    Interventions:   Device: Stryker Hybrid;   Device: Erich
    Sponsor:   Emory University
    Recruiting - verified July 2016

  • Conditions:   Visual Acuity at Near;   Accuracy of Accommodation;   Prevention of Strabismus;   Task Readiness
    Interventions:   Device: bifocals;   Device: single vision glasses
    Sponsor:   Radboud University
    Recruiting - verified October 2015

  • Conditions:   Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
    Interventions:   Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
    Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   Fondation pour la Recherche Médicale
    Recruiting - verified April 2016

  • Condition:   Strabismus
    Intervention:   Device: strabismus video goggles
    Sponsors:   University of Zurich;   Albert Bruppacher-Stiftung;   Stiftung OPOS zugunsten von Wahrnehmungsbehinderten
    Recruiting - verified May 2016

  • Condition:   CSF Leak
    Interventions:   Biological: EVICEL® Fibrin Sealant;   Other: Sutures Only
    Sponsor:   Ethicon, Inc.
    Recruiting - verified February 2016

  • Condition:   Convergence Insufficiency
    Intervention:   Procedure: Office-based vergence/accommodative therapy
    Sponsors:   Salus University;   National Eye Institute (NEI);   Marshall B. Ketchum University;   Ohio State University;   University of Alabama at Birmingham;   State University of New York College of Optometry;   Akron Children's Hospital;   Nova Southeastern University;   Bascom Palmer Eye Institute
    Recruiting - verified November 2015

  • Condition:   Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)
    Interventions:   Biological: MEDI-551;   Other: Placebo
    Sponsor:   MedImmune LLC
    Recruiting - verified September 2016

  • Conditions:   Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
    Intervention:   Drug: Amifampridine Phosphate
    Sponsors:   Catalyst Pharmaceuticals, Inc.;   DM-STAT, Inc;   First Stop Consulting
    Available - verified May 2016

  • Condition:   Carotid Stenosis
    Interventions:   Procedure: Regional anesthesia;   Procedure: General anesthesia;   Device: Transcranial Doppler ultrasonography;   Procedure: blood gas analysis;   Procedure: invasive arterial blood pressure measurement;   Procedure: arterial blood gas measurement;   Behavioral: Neurological Control;   Behavioral: NIRS monitoring;   Device: oxygen supply (not invasive 'Vigileo')
    Sponsor:   Medical University Innsbruck
    Recruiting - verified April 2016

  • Condition:   Leber's Hereditary Optic Neuropathy
    Interventions:   Drug: injection of scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: injection of scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: injection of scAAV2-P1ND4v2 1.0X10e11vg (High)
    Sponsors:   John Guy;   National Eye Institute (NEI)
    Recruiting - verified June 2016

  • Conditions:   Glaucoma, Suspect;   Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System;   Congenital Coloboma of the Optic Nerve;   Optic Nerve Head Pits, Bilateral Congenital
    Interventions:   Device: Cartoon video fixation target and cartoon character voice audio instructions during Humphrey perimetry;   Other: Usual Care procedures during Humphrey perimetry for children
    Sponsor:   Nova Southeastern University
    Recruiting - verified October 2015

  • Conditions:   Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
    Interventions:   Drug: TPI 287 2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
    Sponsors:   University of California, San Francisco;   CBD Solutions;   Tau Consortium
    Recruiting - verified January 2016

  • Condition:   Brain Tumor
    Intervention:   Behavioral: Physical Activity
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified March 2016

  • Conditions:   Neurofibromatosis Type 2;   Vestibular Schwannomas
    Intervention:   Drug: Axitinib
    Sponsor:   New York University School of Medicine
    Recruiting - verified April 2016

  • Condition:   Brain Injuries, Traumatic
    Intervention:   Device: Balance and Gait Training using neurostimulation modulation.
    Sponsor:   University of Wisconsin, Madison
    Recruiting - verified November 2015

  • Condition:   Trigeminal Neuralgia
    Interventions:   Biological: Incobotulinumtoxina;   Other: Placebo Comparator
    Sponsors:   Thomas Jefferson University;   Merz Pharmaceuticals, LLC
    Recruiting - verified June 2016

  • Condition:   Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
    Interventions:   Drug: SA237;   Drug: Placebo
    Sponsor:   Chugai Pharmaceutical
    Recruiting - verified July 2016

  • Conditions:   Alzheimer's Disease (AD);   Parkinson's Disease (PD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
    Intervention:   Drug: [18F]T807 ([18F]MNI-777)
    Sponsors:   Molecular NeuroImaging;   Institute for Neurodegenerative Disorders
    Recruiting - verified April 2016

  • Conditions:   Sporadic Acoustic Neuromas;   Useful Hearing
    Intervention:   Radiation: Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting - verified October 2015

  • Conditions:   Neuromyelitis Optica (NMO);   NMO Spectrum Disorder (NMOSD)
    Interventions:   Drug: SA237;   Drug: Placebo
    Sponsor:   Chugai Pharmaceutical
    Recruiting - verified June 2016

  • Condition:   Brain Tumor Treated With Cranial or Cranial-Spinal Radiation
    Interventions:   Drug: Metformin;   Drug: Placebo
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified August 2016

  • Condition:   Optic Neuritis
    Intervention:   Drug: ACTHAR
    Sponsors:   Neuro-Ophthalmologic Associates, PC;   Mallinckrodt
    Recruiting - verified September 2016

  • Conditions:   Brain Metastasis;   Spinal Tumors;   Lung Tumors;   Ependymoma
    Intervention:   Radiation: SBRT treatment
    Sponsor:   Centre Leon Berard
    Recruiting - verified May 2016

  • Condition:   Parkinson's Disease
    Intervention:   Other: biweekly treatment intervention
    Sponsor:   Zia, Al Raza
    Recruiting - verified July 2016

  • Condition:   Optic Neuritis
    Interventions:   Drug: Erythropoietin alfa;   Drug: Placebo
    Sponsors:   University Eye Hospital, Freiburg;   German Federal Ministry of Education and Research
    Recruiting - verified April 2016

  • Condition:   Vestibular Schwannoma
    Intervention:   Radiation: Initial Gamma knife radiosurgery
    Sponsor:   Karolinska Institutet
    Recruiting - verified August 2016

  • Conditions:   Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
    Interventions:   Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
    Sponsors:   Retina Associates of South Florida;   MD Stem Cells
    Recruiting - verified September 2016

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: Eculizumab
    Sponsor:   Alexion Pharmaceuticals
    Recruiting - verified April 2016

  • Conditions:   Neurofibromatosis Type 2;   Vestibular Schwannomas;   Meningiomas
    Intervention:   Drug: RAD001
    Sponsor:   New York University School of Medicine
    Recruiting - verified August 2016

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting - verified August 2016

  • Conditions:   Neurofibromatosis 1;   Neurofibromatosis 2;   Schwannomatosis
    Intervention:  
    Sponsor:   The Children's Tumor Foundation
    Recruiting - verified January 2016

  • Conditions:   Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
    Interventions:   Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
    Sponsors:   Mark Atlas;   Janssen Pharmaceuticals
    Recruiting - verified July 2016

  • Conditions:   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
    Sponsors:   Sanjiv Sam Gambhir;   National Cancer Institute (NCI)
    Recruiting - verified November 2015

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated
    Recruiting - verified September 2016

  • Conditions:   Strabismus;   Esotropia;   Exotropia
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting - verified September 2015

  • Condition:   Traumatic Optic Neuropathy
    Intervention:   Drug: Recombinant human erythropoietin (EPO)
    Sponsors:   Tehran University of Medical Sciences;   Iran University of Medical Sciences;   Mashhad University of Medical Sciences;   Shahid Beheshti University of Medical Sciences
    Recruiting - verified April 2016

  • Conditions:   Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
    Intervention:  
    Sponsor:   Milton S. Hershey Medical Center
    Recruiting - verified September 2016

  • Conditions:   Neurofibromatosis Type 2;   Progressive Vestibular Schwannomas
    Intervention:   Drug: Bevacizumab
    Sponsors:   University of Alabama at Birmingham;   Genentech, Inc.
    Recruiting - verified September 2016

  • Conditions:   Amblyopia ex Strabismus;   Amblyopia ex Anisometropia
    Interventions:   Device: Dynamic Vessel Analyzer;   Other: Laser Doppler Velocimetry;   Device: 7-Tesla MRI;   Other: Pattern electroretinography;   Other: Fourier domain optical coherence tomography
    Sponsor:   Medical University of Vienna
    Recruiting - verified February 2016

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: Verum arm receiving Gilenya®;   Drug: Active Comparator receiving Extavia®
    Sponsors:   Charite University, Berlin, Germany;   NeuroCure Clinical Research Center
    Recruiting - verified January 2016

  • Conditions:   Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
    Intervention:   Drug: Bupivacaine
    Sponsors:   Smith-Kettlewell Eye Research Institute;   Eidactics;   Sutter Health;   Strabismus Research Foundation
    Recruiting - verified November 2015

  • Conditions:   Binocular Vision Dysfunction;   Vertical Heterophoria
    Intervention:   Other: Questionnaires and Optometrist Prism Challenge/Treatment
    Sponsors:   Vision Specialists of Birmingham;   Saint Joseph Mercy Health System
    Recruiting - verified December 2015

  • Conditions:   Adenoid Cystic Carcinoma;   Squamous Cell Carcinoma;   Sinonasal Carcinoma;   Sinonasal Undifferentiated Carcinoma;   Mucoepidermoid Carcinoma;   Schneiderian Carcinoma;   Myoepithelial Carcinoma;   Esthesioneuroblastoma;   Melanoma
    Interventions:   Radiation: Proton radiation therapy;   Radiation: Intensity-modulated radiotherapy
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting - verified February 2016

  • Condition:   Orbital Fractures
    Interventions:   Procedure: operative fracture size vs CT fracture size;   Procedure: orbital fracture intraoperative measurement
    Sponsor:   HaEmek Medical Center, Israel
    Recruiting - verified September 2016

  • Conditions:   Neurofibromatosis Type 2;   Neuroma, Acoustic
    Intervention:   Drug: RAD001, everolimus
    Sponsors:   Jonsson Comprehensive Cancer Center;   Novartis Pharmaceuticals
    Recruiting - verified August 2016

  • Conditions:   Multiple Sclerosis;   Optic Neuritis
    Intervention:   Drug: Mangafodipir (Teslascan)
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified June 2016

  • Conditions:   Brain Tumor;   Head and Neck Tumor;   Skull Base Tumor
    Intervention:   Procedure: PET scan
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified June 2016

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified June 2016

  • Condition:   Esotropia
    Interventions:   Procedure: mVEP Testing;   Procedure: Stereoacuity Testing;   Procedure: Optokinetic nystagmus testing;   Procedure: Motion detection testing;   Procedure: Motion discrimination testing
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified May 2016

  • Condition:   Neuroma, Acoustic
    Interventions:   Procedure: Microsurgery;   Procedure: Stereotactic radiation therapy
    Sponsors:   Stanford University;   University of Cincinnati;   Baylor College of Medicine;   Weill Medical College of Cornell University;   University of Iowa;   University of Texas;   George Washington University;   Indiana University
    Recruiting - verified April 2016

  • Conditions:   Neurofibromatosis Type 1;   Malignant Peripheral Nerve Sheath Tumor;   Plexiform Neurofibroma;   Optic Glioma;   Neurofibroma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified March 2016

  • Conditions:   Childhood Atypical Teratoid/Rhabdoid Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
    Intervention:   Other: cytology specimen collection procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified May 2016

  • Condition:   Anterior Ischemic Optic Neuropathy
    Intervention:   Drug: Diagnostic procedures
    Sponsor:   Bayer
    Recruiting - verified August 2016

  • Condition:   Devic's Disease
    Intervention:   Procedure: Hematopoietic stem cell transplantation
    Sponsor:   Northwestern University
    Recruiting - verified September 2016

  • Conditions:   Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified November 2015


PaidClinicalTrials.orgPaidClinicalTrials.org